Published in Arch Neurol on March 01, 1991
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2008) 3.21
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 2.49
CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology (2008) 2.43
Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 1.99
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Racial differences in disability after stroke: results from a nationwide study. Neurology (2014) 1.65
Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry (2003) 1.60
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet (2014) 1.56
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52
Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology (2008) 1.48
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry (2010) 1.43
Metacognitive deficits in frontotemporal dementia. J Neurol Neurosurg Psychiatry (2005) 1.39
Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.39
Selective impairment of frontal-executive cognitive function in african americans with cardiovascular risk factors. J Am Geriatr Soc (2003) 1.38
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34
Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement (2008) 1.32
The ageing brain: normal and abnormal memory. Philos Trans R Soc Lond B Biol Sci (1997) 1.24
Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol (2012) 1.23
Prevention of Alzheimer disease. Encouraging evidence. Can Fam Physician (2006) 1.21
Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time. Alzheimer Dis Assoc Disord (2011) 1.19
Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey. BMC Neurol (2009) 1.18
Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis. J Neurosci (2010) 1.14
Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.13
Neuropsychological function in nondemented carriers of presenilin-1 mutations. Neurology (2005) 1.13
Changes in cognition. Neurobiol Aging (2011) 1.06
Relative telomere length and cognitive decline in the Nurses' Health Study. Neurosci Lett (2011) 1.04
Dietary fat intake and cognitive decline in women with type 2 diabetes. Diabetes Care (2009) 1.02
Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease. J Neurol (2005) 1.01
Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J Gerontol A Biol Sci Med Sci (2009) 1.01
Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. J Psychiatry Neurosci (2009) 1.00
Tooth loss, apolipoprotein E, and decline in delayed word recall. J Dent Res (2010) 0.99
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Neurobiol Aging (2010) 0.98
Confirmatory factor analysis of the ADNI Neuropsychological Battery. Brain Imaging Behav (2012) 0.95
Disorders of semantic memory. J Neurol Neurosurg Psychiatry (1997) 0.95
Memory deficits in schizophrenia: inadequate assimilation or true amnesia? Findings from the Wechsler Memory Scale--revised. J Psychiatry Neurosci (1997) 0.94
Informant-based dementia screening in a population-based sample of African Americans. Alzheimer Dis Assoc Disord (2009) 0.93
Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia. Neuropsychopharmacology (2015) 0.92
Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studies. Front Psychiatry (2014) 0.92
Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. Curr Alzheimer Res (2009) 0.91
Physical activity levels and cognition in women with type 2 diabetes. Am J Epidemiol (2009) 0.91
Clinical applications of neuropsychological assessment. Dialogues Clin Neurosci (2012) 0.91
Total antioxidant capacity of diet in relation to cognitive function and decline. Am J Clin Nutr (2010) 0.89
Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology (2016) 0.88
Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases. Arch Clin Neuropsychol (2010) 0.88
Neuropsychological predictors of dementia in late-life major depressive disorder. Am J Geriatr Psychiatry (2013) 0.87
Everyday experiences of memory problems and control: the adaptive role of selective optimization with compensation in the context of memory decline. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2014) 0.87
Exercise rehabilitation on home-dwelling patients with Alzheimer's disease--a randomized, controlled trial. Study protocol. Trials (2010) 0.86
How Stereotype Threat Affects Healthy Older Adults' Performance on Clinical Assessments of Cognitive Decline: The Key Role of Regulatory Fit. J Gerontol B Psychol Sci Soc Sci (2015) 0.85
The association of antioxidants and cognition in the Nurses' Health Study. Am J Epidemiol (2012) 0.85
Gonadal hormones and cognitive aging: a midlife perspective. Womens Health (Lond Engl) (2011) 0.84
Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice. PLoS One (2013) 0.83
Neural correlates of true and false memory in mild cognitive impairment. PLoS One (2012) 0.83
[CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)]. Z Gerontol Geriatr (2009) 0.82
Selective control of attention supports the positivity effect in aging. PLoS One (2014) 0.81
Daily stress magnifies the association between cognitive decline and everyday memory problems: an integration of longitudinal and diary methods. Psychol Aging (2014) 0.81
Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol (2009) 0.81
Categorization of novel tools by patients with Alzheimer's disease: category-specific content and process. Neuropsychologia (2009) 0.80
Fornix White Matter is Correlated with Resting-State Functional Connectivity of the Thalamus and Hippocampus in Healthy Aging but Not in Mild Cognitive Impairment - A Preliminary Study. Front Aging Neurosci (2015) 0.79
Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers. Cortex (2014) 0.79
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease. Genome Med (2016) 0.78
A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial. Alzheimers Dement (2014) 0.78
Machine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategy. J Int Neuropsychol Soc (2012) 0.78
Decreased cognitive function in extended family members from the single late-onset-Alzheimer's-disease pedigree. J Int Neuropsychol Soc (2013) 0.78
The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly. BMC Psychiatry (2014) 0.78
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain. J Neurosci (2016) 0.77
A preclinical cognitive test battery to parallel the National Institute of Health Toolbox in humans: bridging the translational gap. Neurobiol Aging (2013) 0.77
Effects of epsilon4 on object recognition in the non-demented elderly. Curr Aging Sci (2010) 0.77
Cognitive aging and Alzheimer's disease. Postgrad Med J (2005) 0.77
Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial. Trials (2012) 0.77
Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia. J Int Neuropsychol Soc (2009) 0.77
The use of profanity during letter fluency tasks in frontotemporal dementia and Alzheimer disease. Cogn Behav Neurol (2010) 0.77
Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory Impairments. Front Aging Neurosci (2016) 0.75
Cognition, Depressive Symptoms and Vascular Factors among Southwest Tribal Elders. Ethn Dis (2016) 0.75
Slow Progression of Cognitive Dysfunction of Alzheimer's Disease in Sexagenarian Women with Schizophrenia. Case Rep Psychiatry (2015) 0.75
Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum. Innov Clin Neurosci (2017) 0.75
The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study. Dement Geriatr Cogn Dis Extra (2014) 0.75
A comparison of theoretical and statistically derived indices for predicting cognitive decline. Alzheimers Dement (Amst) (2016) 0.75
Delayed audiovisual integration of patients with mild cognitive impairment and Alzheimer's disease compared with normal aged controls. J Alzheimers Dis (2012) 0.75
Shift work and cognition in the Nurses' Health Study. Am J Epidemiol (2013) 0.75
Reward Dependent Invigoration Relates to Theta Oscillations and Is Predicted by Dopaminergic Midbrain Integrity in Healthy Elderly. Front Aging Neurosci (2017) 0.75
An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog). Psychol Assess (2016) 0.75
Impairments in the Face-Processing Network in Developmental Prosopagnosia and Semantic Dementia. Cogn Behav Neurol (2015) 0.75
Genetic variants specific to aging-related verbal memory: Insights from GWASs in a population-based cohort. PLoS One (2017) 0.75
Cognitive and behavioral evaluation of nutritional interventions in rodent models of brain aging and dementia. Clin Interv Aging (2017) 0.75
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
Endogenous opioid peptides: multiple agonists and receptors. Nature (1977) 8.21
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology (1998) 7.27
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology (1994) 5.81
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA (1992) 5.07
Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep (1998) 4.85
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol (1972) 4.11
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
The use of an optical brightener in the study of plant structure. Stain Technol (1975) 3.70
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04
Chronic conditions and risk of in-hospital death. Health Serv Res (1994) 3.00
Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ (1997) 2.87
High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol (1993) 2.77
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology (1995) 2.69
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull (1988) 2.50
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.36
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther (2015) 2.34
Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34
Computer-assisted interview of patients with functional headache. Arch Intern Med (1972) 2.31
Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. Clin Radiol (2011) 2.30
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Errors in using tobacco withdrawal scale. Tob Control (1998) 2.23
Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1992) 2.19
Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry (1990) 2.18
Alzheimer's disease: a study of epidemiological aspects. Ann Neurol (1984) 2.17
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology (1997) 2.13
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Osteopontin--a molecule for all seasons. QJM (2002) 2.09
Lymphogranuloma Venereum: A Histologic Study of the Primary Lesion, Bubonulus, and Lymph Nodes in Cases Proved by Isolation of the Virus. Am J Pathol (1947) 2.07
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn (1992) 1.98
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr (2004) 1.97
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
A prokaryotic phytochrome. Nature (1997) 1.91
Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol (1990) 1.90
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 1.89
The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology (1993) 1.89
Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci (1975) 1.88
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care (2005) 1.87
Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis (1979) 1.85
Value of routine chest radiography of psychiatric patients. Br Med J (1980) 1.84
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia (1992) 1.82
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol (1997) 1.82
The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol (1998) 1.82
Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol (1998) 1.79
Incorporation of labelled amino acids into the enkephalins. FEBS Lett (1977) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res (1991) 1.71
Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci (1975) 1.71
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
The pilot Stroke Data Bank: definition, design, and data. Stroke (1984) 1.67
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc (1991) 1.67
Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1995) 1.64
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol (2003) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Characterization of recombinant phytochrome from the cyanobacterium Synechocystis. Proc Natl Acad Sci U S A (1997) 1.60
Intensive care-management at home: an alternative to institutional care? Age Ageing (2001) 1.58
Lead exposure in a firing range. Am J Public Health (1987) 1.58
In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol (1977) 1.56
Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol (1973) 1.56
Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol (1986) 1.54
A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technol Assess (2006) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology (1995) 1.51